Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2010 Apr 30:11:48.
doi: 10.1186/1745-6215-11-48.

Protocol for a randomised controlled trial investigating the effectiveness of an online e-health application compared to attention placebo or sertraline in the treatment of generalised anxiety disorder

Helen Christensen  1 , Adam J Guastella, Andrew J Mackinnon, Kathleen M Griffiths, Claire Eagleson, Philip J Batterham, Kanupriya Kalia, Justin Kenardy, Kylie Bennett, Ian B Hickie
Affiliations
Randomized Controlled Trial

Protocol for a randomised controlled trial investigating the effectiveness of an online e-health application compared to attention placebo or sertraline in the treatment of generalised anxiety disorder

Helen Christensen et al. Trials. .

Abstract

Background: Generalised anxiety disorder (GAD) is a high prevalence, chronic psychiatric disorder which commonly presents early in the lifespan. Internet e-health applications have been found to be successful in reducing symptoms of anxiety and stress for post traumatic stress disorder (PTSD), panic disorder, social phobia and depression. However, to date, there is little evidence for the effectiveness of e-health applications in adult GAD. There are no studies which have directly compared e-health applications with recognised evidence-based medication. This study aims to determine the effectiveness of a web-based program for treating GAD relative to sertraline and attention placebo.

Methods/design: 120 community-dwelling participants, aged 18-30 years with a clinical diagnosis of GAD will be recruited from the Australian Electoral Roll. They will be randomly allocated to one of three conditions: (i) an online treatment program for GAD, E-couch (ii) pharmacological treatment with a selective serotonin re-uptake inhibitor (SSRI), sertraline (a fixed-flexible dose of 25-100 mg/day) or (iii) an attention control placebo, HealthWatch. The treatment program will be completed over a 10 week period with a 12 month follow-up.

Discussion: As of February 2010, there were no registered trials evaluating the effectiveness of an e-health application for GAD for young adults. Similarly to date, this will be the first trial to compare an e-health intervention with a pharmacological treatment.

Trial registration: Current Controlled Trials ISRCTN76298775.

PubMed Disclaimer

References

    1. American Psychiatric Association. Diagnostic and statistical manual of mental disorders: DSM-IV. 4. Washington, DC: American Psychiatric Association; 1994.
    1. Judd LL, Kessler RC, Paulus MP, Zeller PV, Wittchen HU, Kunovac JL. Comorbidity as a fundamental feature of generalized anxiety disorders: results from the National Comorbidity Study (NCS) Acta Psychiatr Scand Suppl. 1998;393:6–11. doi: 10.1111/j.1600-0447.1998.tb05960.x. - DOI - PubMed
    1. Tyrer P, Baldwin D. Generalised anxiety disorder. Lancet. 2006;368:2156–2166. doi: 10.1016/S0140-6736(06)69865-6. - DOI - PubMed
    1. Wittchen H. In: Unmet Need in Psychiatry. Andrews G, Henderson S., editor. Cambridge: Cambridge University Press; 2000. Met and unmet need for interventions in community cases with anxiety disorders; pp. 256–276. full_text.
    1. Feldner MT, Zvolensky MJ, Schmidt NB. Prevention of anxiety psychopathology: a critical review of the empirical literature. Clinical Psychology: Science and Practice. 2004;11:405–424. doi: 10.1093/clipsy/bph098. - DOI

Publication types

Associated data